 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
7 December 2004 | Volume 141 Issue 11 | Pages 835-838
Background: Implantable cardioverter defibrillators (ICDs) can prevent premature death from an arrhythmia but may also prolong the dying process and make it more distressing.
Objective: To describe the frequency, timing, and correlates of discussions about deactivating ICDs.
Design: Retrospective cohort study.
Setting: Telephone survey.
Participants: Next of kin of patients with ICDs who died of any cause. Of 136 next of kin contacted, 100 (74%) participated.
Measurements: Incidence of discussions about deactivating ICDs and timing of last shock from ICD.
Results: Next of kin reported that clinicians discussed deactivating the ICD in only 27 of the 100 cases. Most discussions occurred in the last few days of life. Family members reported that 8 patients received a shock from their ICD in the minutes before death.
Limitations: This retrospective survey relied on the reports of next of kin.
Conclusions: Next of kin reported that clinicians discussed deactivating ICDs with few patients. Individuals who choose to receive this device should have the opportunity to choose to discontinue it as death approaches.
Editors' Notes
Context
Contribution
Implications
–The Editors
Author and Article Information
From the Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, Connecticut; and the Washington Home Center for Palliative Care Studies, Washington, DC.
Acknowledgments: The authors thank Barbara Mendes and Joanne McGloin at the Program on Aging, Yale University, for their assistance with data collection. The After-Death Bereaved Family Interview of the Toolkit of Instruments to Measure End-of-Life Care is used with permission of Joan Teno, MD, MS, Center for Gerontology and Health Care Research, Brown Medical School, Providence, Rhode Island.
Grant Support: Dr. Goldstein was a Robert Wood Johnson Clinical Scholar funded by the Department of Veterans Affairs during the course of this study. Dr. Lampert is supported by American Heart Association grant #0030190N. Dr. Bradley is supported by the Patrick and Catherine Weldon Donaghue Medical Research Foundation (Donaghue Investigator Award grant #02-102) and the Claude D. Pepper Older Americans Independence Center at Yale University (#P30AG21342). Dr. Lynn is supported by The Washington Home Center for Palliative Care Studies.
Potential Financial Conflicts of Interest:Expert testimony: J. Lynn (Medicare Coverage Advisory Committee).
Requests for Single Reprints: Nathan E. Goldstein, MD, Department of Geriatrics, Mount Sinai Medical Center, Box 1070, One Gustave L. Levy Place, New York, NY 10029; e-mail, nathan.goldstein{at}mssm.edu.
Current Author Addresses: Dr. Goldstein: Brookdale Department of Geriatrics, Box 1070, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, NY 10029.
Dr. Lampert: Section of Cardiovascular Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208017, New Haven, CT 06510.
Dr. Bradley: Yale School of Public Health, 60 College Street, PO Box 208034, New Haven, CT 06520.
Dr. Lynn: The Washington Home Center for Palliative Care Studies, 3720 Upton Street, NW, Washington, DC 20016.
Dr. Krumholz: Clinical Scholars Program, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520-8025.
Author Contributions: Conception and design: N.E. Goldstein, R. Lampert, J. Lynn, H.M. Krumholz.
Analysis and interpretation of the data: N.E. Goldstein, R. Lampert, E. Bradley, J. Lynn, H.M. Krumholz.
Drafting of the article: N.E. Goldstein.
Critical revision of the article for important intellectual content: N.E. Goldstein, R. Lampert, E. Bradley, J. Lynn, H.M. Krumholz.
Final approval of the article: N.E. Goldstein, R. Lampert, E. Bradley, J. Lynn, H.M. Krumholz.
Provision of study materials or patients: R. Lampert.
Statistical expertise: N.E. Goldstein.
Obtaining of funding: H.M. Krumholz.
Administrative, technical, or logistic support: N.E. Goldstein.
Collection and assembly of data: N.E. Goldstein. ARTICLE
Management of Implantable Cardioverter Defibrillators in End-of-Life Care
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  B. L. Wilkoff, A. Auricchio, J. Brugada, M. Cowie, K. A. Ellenbogen, A. M. Gillis, D. L. Hayes, J. G. Howlett, J. Kautzner, C. J. Love, et al. HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations: Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association Europace, June 1, 2008; 10(6): 707 - 725. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation, May 27, 2008; 117(21): e350 - e408. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Matlock Implantable Cardioverter-Defibrillators, Heart Failure, and Patient Characteristics JAMA, January 23, 2008; 299(3): 285 - 286. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Hauptman Palliation in heart failure: When less and more are more American Journal of Hospice and Palliative Medicine, March 1, 2006; 23(2): 150 - 152. [PDF]
|
|
|
|
 |
|
 J. M. Beattie, M. J. Connolly, and J. E. Ellershaw Deactivating Implantable Cardioverter Defibrillators Ann Intern Med, November 1, 2005; 143(9): 690 - 691. [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Dunbar Psychosocial Issues of Patients With Implantable Cardioverter Defibrillators Am. J. Crit. Care., July 1, 2005; 14(4): 294 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Berger The Ethics of Deactivating Implanted Cardioverter Defibrillators Ann Intern Med, April 19, 2005; 142(8): 631 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Morrison and C. T. Sinclair Next-of-Kin Responses and Do-Not-Resuscitate Implications for Implantable Cardioverter Defibrillators Ann Intern Med, April 19, 2005; 142(8): 676 - 677. [Full Text] [PDF]
|
|
|
|
|
|
R. E. Enck Management of cardiac devices as the end nears American Journal of Hospice and Palliative Medicine, January 1, 2005; 22(1): 7 - 8. [PDF]
|
|
Read all Rapid Responses
Article
